ID: ALA5266838

Max Phase: Preclinical

Molecular Formula: C17H18N6O

Molecular Weight: 322.37

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]ncn1-c1ccc(-c2ccc(N3CCNCC3)nc2)cc1

Standard InChI:  InChI=1S/C17H18N6O/c24-17-21-20-12-23(17)15-4-1-13(2-5-15)14-3-6-16(19-11-14)22-9-7-18-8-10-22/h1-6,11-12,18H,7-10H2,(H,21,24)

Standard InChI Key:  JASKIAKXFGASHC-UHFFFAOYSA-N

Associated Targets(Human)

Glucose-dependent insulinotropic receptor 4762 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.37Molecular Weight (Monoisotopic): 322.1542AlogP: 1.03#Rotatable Bonds: 3
Polar Surface Area: 78.84Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.50CX Basic pKa: 8.69CX LogP: 1.53CX LogD: 0.47
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -1.55

References

1. Kerru N, Singh-Pillay A, Awolade P, Singh P..  (2018)  Current anti-diabetic agents and their molecular targets: A review.,  152  [PMID:29751237] [10.1016/j.ejmech.2018.04.061]

Source